Literature DB >> 22345656

IL28B polymorphisms do not predict response to therapy in chronic hepatitis C with HCV genotype 5.

Nabil Antaki, Stéphanie Bibert, Kamel Kebbewar, Fouad Asaad, Osama Baroudi, Sawsan Alideeb, Milad Hadad, Dirar Abboud, Houda Sabah, Pierre-Yves Bochud, Francesco Negro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22345656     DOI： 10.1136/gutjnl-2012-302019

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  4 in total

Review 1.  Current status and emerging challenges in the treatment of hepatitis C virus genotypes 4 to 6.

Authors:  Vasilios Papastergiou; Stylianos Karatapanis
Journal:  World J Clin Cases       Date:  2015-03-16       Impact factor: 1.337

Review 2.  Sustained virologic response to standard interferon or pegylated interferon and ribavirin in patients with hepatitis C virus genotype 5: systematic review and meta-analysis of ten studies and 423 patients.

Authors:  Pardha Devaki; David Jencks; Brittany E Yee; Mindie H Nguyen
Journal:  Hepatol Int       Date:  2015-05-28       Impact factor: 6.047

Review 3.  IL28B polymorphisms as a pretreatment predictor of response to HCV treatment.

Authors:  Christoph T Berger; Arthur Y Kim
Journal:  Infect Dis Clin North Am       Date:  2012-12       Impact factor: 5.982

4.  Prevalence of Thymine--Adenine Dinucleotide Repeat, IL28B and IFNL4 in Thai Population and Correlation with Spontaneous Clearance and Treatment Outcome of Hepatitis C Infection.

Authors:  Vo Duy Thong; Rujipat Wasitthankasem; Pisit Tangkijvanich; Sompong Vongpunsawad; Yong Poovorawan
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.